INTERNATIONAL PATENT: INTRA-CELLULAR THERAPIES, INC. FILES APPLICATION FOR "SUBSTITUTED HETEROCYCLES FOR USE IN THE TREATMENT OF DISEASES INVOLVING THE 5-HT2A RECEPTOR"

GENEVA, Jan. 13 -- INTRA-CELLULAR THERAPIES, INC. (135 Route 202/206Suite 6Bedminster, New Jersey 07921) filed a patent application (PCT/US2025/036531) for "SUBSTITUTED HETEROCYCLES FOR USE IN THE TREATMENT OF DISEASES INVOLVING THE 5-HT2A RECEPTOR" on Jul 03, 2025. With publication no. WO/2026/011166, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Peng (c/o Intra-Cellular Therapies, Inc.135 Route 202/206, Suite 6Bedminster, New Jersey 07921), DAVIS, Robert (c/o Intra-Cellular Therapies, Inc.135 Route 202/206, Suite ...